510(k) · Cleared
ClearedAurora Magnetic Resonance Diagnostic Device
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Aurora Imaging Technology, Inc. · LNH System, Nuclear Magnetic Resonance Imaging
Cleared on Sep 19, 2001 after a 70-day review. The summary cites one number, which could not be confirmed as its predicate (see the table below). 4 later devices descend from it.
- Decided
- Sep 19, 2001
- Review
- 70 days
- Class
- Class II
- Product code
- LNH
- Recalls
- None
- Predicates
- 1
4 later devices descend from it, 1 citing it directly.
- This deviceK012154 Aurora Magnetic Resonance Diagnostic DeviceAurora Imaging Technology, Inc. · 2001
- Descendant · cites it directly · 3 of its ownK032082 AuroraAurora Imaging Technology, Inc. · 2003
- Descendant · 2 generations on · 0 of its ownK073425 Modification to Aurora Mri SystemAurora Imaging Technology, Inc. · 2008
- Descendant · 2 generations on · 0 of its ownK052698 Modification to: AuroraAurora Imaging Technology, Inc. · 2005
- Descendant · 2 generations on · 0 of its ownK032678 Modification to: AuroraAurora Imaging Technology, Inc. · 2003
Most influential descendants
Showing 4 of 4 · See all- K032082AuroraAurora Imaging Technology, Inc. · 2003 · cites it directly3descendants
- K073425Modification to Aurora Mri SystemAurora Imaging Technology, Inc. · 2008 · 2 generations on0descendants
- K052698Modification to: AuroraAurora Imaging Technology, Inc. · 2005 · 2 generations on0descendants
- K032678Modification to: AuroraAurora Imaging Technology, Inc. · 2003 · 2 generations on0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| 0 (this device) | K012154 | Aurora Magnetic Resonance Diagnostic Device | Aurora Imaging Technology, Inc. | 2001 | — |
| +1 | K032082 | Aurora | Aurora Imaging Technology, Inc. | 2003 | — |
| +2 | K073425 | Modification to Aurora Mri System | Aurora Imaging Technology, Inc. | 2008 | — |
| +2 | K052698 | Modification to: Aurora | Aurora Imaging Technology, Inc. | 2005 | — |
| +2 | K032678 | Modification to: Aurora | Aurora Imaging Technology, Inc. | 2003 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2003 | 2 | 0 |
| 2005 | 1 | 0 |
| 2008 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LNH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LNH device
- #1 K213693 MAGNETOM Vida with syngo MR XA50Ascore 23.0 · 18 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary; numbers the summary cites that cannot be its predicate are marked – and kept off the family tree.
| Type | Number | Device | Decided |
|---|---|---|---|
| Kept off the family tree | K000356 | FDA’s K000356 is C.T.M. Mobility Scooter, Model H2-686, HS-740, HS-580 Our OCR of the scanned summary read K000356, FDA’s number for C.T.M. Mobility Scooter, Model H2-686, HS-740, HS-580 (Warepalmy Enterprise, LLC (Usa)). Its FDA name has none of the distinctive words the summary uses for the device it names, “AURORA”. Kept off the family tree. | 2000 |
What descends from it? (4)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K032082 | Aurora | 2003 | 3 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- Of its descendants, K032082 (Aurora Imaging Technology, Inc., 2003) has gone furthest, with 3 descendants of its own.
How does its category compare?
All LNH devicesLNH System, Nuclear Magnetic Resonance Imaging: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · LNH
26in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · LNH
122in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LNH
8in 2025
Class I (8 since 2007) Class II/III not classified
Adverse event reports per year · LNH
1,263in 2025
MAUDE reports naming product code LNH, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 12 | 35 | 25 | 114 |
| 2008 | 19 | 53 | 12 | 167 |
| 2009 | 17 | 70 | 7 | 194 |
| 2010 | 12 | 94 | 17 | 165 |
| 2011 | 16 | 81 | 11 | 182 |
| 2012 | 22 | 89 | 5 | 170 |
| 2013 | 19 | 108 | 2 | 107 |
| 2014 | 17 | 108 | 13 | 119 |
| 2015 | 19 | 140 | 12 (2) | 113 |
| 2016 | 20 | 108 | 1 | 135 |
| 2017 | 18 | 98 | 0 | 121 |
| 2018 | 29 | 128 | 71 | 158 |
| 2019 | 26 | 62 | 5 | 158 |
| 2020 | 32 | 121 | 4 | 98 |
| 2021 | 27 | 87 | 41 | 84 |
| 2022 | 30 | 74 | 13 | 138 |
| 2023 | 30 | 124 | 10 (1) | 159 |
| 2024 | 26 | 104 | 4 | 281 |
| 2025 | 26 | 122 | 8 (5) | 1,263 |
| 2026 | 24 | 126 | 43 | — |
What is it indicated for?
The AURORA MR system is an imaging device, and is intended to provide the physician with physiological and clinical information, obtained non-invasively and without the use of ionizing radiation. The MR system produces transverse, coronal, sagittal, and oblique cross-sectional images that display the internal structure of the extremities (breast tissue, axilla, and chest wall local to the breast). The images produced by the MR system reflect the spatial…
Read the full statement (186 words)
The AURORA MR system is an imaging device, and is intended to provide the
physician with physiological and clinical information, obtained non-invasively and
without the use of ionizing radiation. The MR system produces transverse, coronal,
sagittal, and oblique cross-sectional images that display the internal structure of the
extremities (breast tissue, axilla, and chest wall local to the breast). The images
produced by the MR system reflect the spatial distribution of protons (hydrogen
nuclei) exhibiting magnetic resonance. The NMR properties that determine the
image appearance are proton density, spin-lattice relaxation time (T1), spin-spin
relaxation time (12), and flow. When interpreted by a trained physician, these images
provide information that can be useful in diagnosis determination.
The AURORA is a dedicated breast MRl system intended to be used as an adjunct to
conventional breast screening methods.
® Anatomical Region: Breast tissue, axilla, and chest wall local to the breast
® Nucleus excited: Proton
® Diagnostic uses: 2D,3D T1- / T2-weighted imaging
1, 72, proton density measurements
image processing
® Imaging capabilities: 2D Spin Echo (SE)
2D/3D Gradient Echo (GRE)
Fat Suppression
® Imaging processing: Image Subtraction
Imoge Filtering
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K012154 · printed Nov 3, 2026
Cite this page
510(k) Report. “K012154: Aurora Magnetic Resonance Diagnostic Device.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K012154
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026